Vacuna antineumocócica conjugada de quince serotipos en trasplantados de progenitores
Wilck M, Cornely O, Cordonnieru C et al. A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM). Clin Infect Dis published June 20, 2023 https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad349/7203694?login=false Los trasplantados de progenitores hematopoyéticos alogénicos tienen riesgo incrementado de padecer enfermedad…
